Xuejiao Han

1.6k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Xuejiao Han is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Xuejiao Han has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Immunology and 5 papers in Biomedical Engineering. Recurrent topics in Xuejiao Han's work include Nanoplatforms for cancer theranostics (4 papers), Immunotherapy and Immune Responses (3 papers) and Luminescence and Fluorescent Materials (3 papers). Xuejiao Han is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), Immunotherapy and Immune Responses (3 papers) and Luminescence and Fluorescent Materials (3 papers). Xuejiao Han collaborates with scholars based in China, United States and Portugal. Xuejiao Han's co-authors include Yuquan Wei, Xiawei Wei, Aqu Alu, Jingwen Luo, Yang Wang, Ziqi Zhang, Xiawei Wei, Xuelei Ma, Yuan Cheng and Fei Mo and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Catalysis and ACS Applied Materials & Interfaces.

In The Last Decade

Xuejiao Han

20 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mRNA vaccine: a potential therapeutic strategy

2021 286 citations Yang Wang, Ziqi Zhang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuejiao Han China	12	540	504	289	165	145	21	1.1k
Aqu Alu China	13	397 0.7×	364 0.7×	193 0.7×	254 1.5×	125 0.9×	22	1.0k
Jifeng Yu China	19	508 0.9×	694 1.4×	545 1.9×	170 1.0×	235 1.6×	77	1.8k
Anne Richter Germany	21	470 0.9×	875 1.7×	314 1.1×	82 0.5×	192 1.3×	59	1.8k
Christian Kleist Germany	22	511 0.9×	342 0.7×	456 1.6×	65 0.4×	95 0.7×	56	1.3k
Blessing Crimeen‐Irwin Australia	16	904 1.7×	656 1.3×	351 1.2×	125 0.8×	121 0.8×	23	1.6k
Manisha Singh United States	18	282 0.5×	519 1.0×	399 1.4×	84 0.5×	120 0.8×	47	1.2k
Ali Aghebati‐Maleki Iran	16	423 0.8×	237 0.5×	294 1.0×	91 0.6×	234 1.6×	30	1.2k
Ben Quah Australia	19	722 1.3×	1.0k 2.0×	237 0.8×	88 0.5×	90 0.6×	33	1.8k
Flávia Castro Portugal	16	499 0.9×	753 1.5×	554 1.9×	100 0.6×	285 2.0×	31	1.6k

Countries citing papers authored by Xuejiao Han

Since Specialization

Citations

This map shows the geographic impact of Xuejiao Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejiao Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejiao Han more than expected).

Fields of papers citing papers by Xuejiao Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuejiao Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejiao Han. The network helps show where Xuejiao Han may publish in the future.

Co-authorship network of co-authors of Xuejiao Han

This figure shows the co-authorship network connecting the top 25 collaborators of Xuejiao Han. A scholar is included among the top collaborators of Xuejiao Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuejiao Han. Xuejiao Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Xuejiao, Yuan Cheng, Dandan Wan, et al.. (2025). Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway. Cancer Communications. 45(7). 794–812. 2 indexed citations

Li, Peicheng, Yifan Wang, Hao Jiang, et al.. (2025). Al-Modified Dendritic Fibrous Nanosilica Catalyst: Accurately Regulated Acidity for Tunable Product Distribution in 1-Decene Oligomerization. ACS Catalysis. 15(12). 10286–10298.

Han, Xuejiao, Yuan Cheng, Z. X. Jiang, Aqu Alu, & Xuelei Ma. (2024). Honokiol Exhibits Anti-Tumor Effects in Breast Cancer by Modulating the miR-148a-5p-CYP1B1 Axis. The American Journal of Chinese Medicine. 52(6). 1843–1861. 3 indexed citations

Xu, Zhourui, Xuejiao Han, Miaozhuang Fan, et al.. (2023). NIR-II Excitable Water-Dispersible Two-Dimensional Conjugated Polymer Nanoplates for In Vivo Two-Photon Luminescence Bioimaging. ACS Applied Materials & Interfaces. 16(1). 142–152. 4 indexed citations

Han, Xuejiao, Aqu Alu, Hongmei Liu, et al.. (2022). Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy. Bioactive Materials. 17. 29–48. 105 indexed citations

Alu, Aqu, et al.. (2022). BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies. Journal of Hematology & Oncology. 15(1). 138–138. 86 indexed citations

Han, Xuejiao, et al.. (2022). Backbone flexibility/amphiphilicity modulation of AIE active polyelectrolytes for mitochondria- and nucleus-targeted synergistic photodynamic therapy of cancer cells. Materials Chemistry Frontiers. 6(24). 3678–3690. 6 indexed citations

Zhou, Huichao, Ningbo Chen, Yaguang Ren, et al.. (2022). Unveiling the improved targeting migration of mesenchymal stem cells with CXC chemokine receptor 3-modification using intravital NIR-II photoacoustic imaging. Journal of Nanobiotechnology. 20(1). 307–307. 10 indexed citations

Cheng, Yuan, Fei Mo, Qingfang Li, et al.. (2021). Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin. Molecular Cancer. 20(1). 62–62. 143 indexed citations

10.

Cheng, Yuan, Xuejiao Han, Fei Mo, et al.. (2021). Apigenin inhibits the growth of colorectal cancer through down-regulation of E2F1/3 by miRNA-215-5p. Phytomedicine. 89. 153603–153603. 34 indexed citations

11.

He, Zhiguo, et al.. (2021). Miniemulsion polymerization-formulated poly(fluorene-alt-6-(2-ethylhexyl)-[1,2,5]thiadiazole[3,4-f]benzotriazole) for cancer cell imaging. Reactive and Functional Polymers. 170. 105130–105130. 4 indexed citations

12.

Xia, Ruolan, Yuan Cheng, Xuejiao Han, Yuquan Wei, & Xiawei Wei. (2021). Ikaros Proteins in Tumor: Current Perspectives and New Developments. Frontiers in Molecular Biosciences. 8. 788440–788440. 11 indexed citations

13.

Wang, Yang, Ziqi Zhang, Jingwen Luo, et al.. (2021). mRNA vaccine: a potential therapeutic strategy. Molecular Cancer. 20(1). 33–33. 286 indexed citations breakdown →

14.

Han, Xuejiao, et al.. (2021). Distinct Characteristics of COVID-19 Infection in Children. Frontiers in Pediatrics. 9. 619738–619738. 17 indexed citations

15.

Han, Xuejiao, Jing Yang, Jingwen Luo, et al.. (2021). Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning Methods. Frontiers in Oncology. 11. 606677–606677. 15 indexed citations

16.

Wang, Yang, Jingwen Luo, Aqu Alu, et al.. (2020). cGAS-STING pathway in cancer biotherapy. Molecular Cancer. 19(1). 136–136. 265 indexed citations

17.

Han, Xuejiao, Xuelei Ma, Yang Li, et al.. (2020). Progress in Neoantigen Targeted Cancer Immunotherapies. Frontiers in Cell and Developmental Biology. 8. 728–728. 32 indexed citations

18.

Song, Yang, Xuejiao Han, Jing Hu, et al.. (2020). Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling. Frontiers in Oncology. 10. 542007–542007. 6 indexed citations

19.

Alu, Aqu, Xuejiao Han, Xuelei Ma, et al.. (2020). The role of lysosome in regulated necrosis. Acta Pharmaceutica Sinica B. 10(10). 1880–1903. 80 indexed citations

20.

Han, Xuejiao, et al.. (2020). Hyperprogression: A novel response pattern under immunotherapy. SHILAP Revista de lepidopterología. 10(5). e167–e167. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact